Daily Cosmetic Research Analysis
Three impactful studies shape cosmetic and aesthetic medicine today: a nonhuman primate model demonstrates that intra-arterial hyaluronidase can partially restore vision after hyaluronic acid filler-induced ophthalmic artery embolism within a 24-hour window; a systematic review indicates adipose tissue browning promotes fat graft retention via angiogenesis and inflammation reduction; and a mixed-methods global synthesis quantifies non-surgical aesthetic treatment complications and prioritizes sa
Summary
Three impactful studies shape cosmetic and aesthetic medicine today: a nonhuman primate model demonstrates that intra-arterial hyaluronidase can partially restore vision after hyaluronic acid filler-induced ophthalmic artery embolism within a 24-hour window; a systematic review indicates adipose tissue browning promotes fat graft retention via angiogenesis and inflammation reduction; and a mixed-methods global synthesis quantifies non-surgical aesthetic treatment complications and prioritizes safety surveillance.
Research Themes
- Safety surveillance and risk stratification in non-surgical aesthetic treatments
- Mechanistic and translational models for filler-induced vascular occlusion and rescue
- Biological augmentation of fat graft retention via adipose browning
Selected Articles
1. Nonhuman Primate Model of Super-selective Intra-arterial Ophthalmic Arterial Interventional Thrombolysis for Treatment of Ophthalmic Arterial Embolism Resulting From Hyaluronic Acid Filler Cosmetic Injection.
A rhesus monkey model of ophthalmic artery embolism from HA filler was established and reperfused via super-selective intra-arterial hyaluronidase thrombolysis. Recanalization at 1, 4, or even 24 hours improved visual function but residual dysfunction and retinal injury persisted; single-cell RNA-seq showed decreased rhodopsin expression with longer ischemia.
Impact: This translational primate model fills an evidence gap for managing filler-induced blindness and suggests a clinically meaningful treatment window for intra-arterial hyaluronidase.
Clinical Implications: Supports considering super-selective intra-arterial hyaluronidase thrombolysis within up to 24 hours after HA filler-related ophthalmic artery embolism, while counseling patients about residual deficits.
Key Findings
- Established a rhesus monkey model of ophthalmic artery embolization by intra-arterial HA injection and achieved reperfusion via intra-arterial hyaluronidase.
- Recanalization at 1, 4, and 24 hours improved visual function, though some dysfunction persisted on electroretinography.
- Histology confirmed retinal cellular damage post-embolization; scRNA-seq revealed decreased rhodopsin expression with longer ischemia time.
Methodological Strengths
- Translational nonhuman primate model closely simulating clinical OA ischemia-reperfusion.
- Multimodal assessment (DSA, fluorescein angiography, ERG, histology/TEM, scRNA-seq) across defined time windows.
Limitations
- Preclinical animal study with unspecified sample size; no randomized comparator or dose-finding.
- Residual functional impairment despite reperfusion; long-term outcomes not assessed.
Future Directions: Prospective clinical registries and controlled trials to define optimal dosing, timing, and adjuncts for intra-arterial hyaluronidase; validation of molecular markers as prognostic indicators.
BACKGROUND: Although intravascular interventional thrombolysis therapy is beneficial for patients suffering from impaired vision caused by hyaluronic acid (HA) embolism, there is no medical evidence-base for the efficacy of this treatment. OBJECTIVES: The aim of this study was to show that intra-arterial thrombolysis therapy (IATT) can effectively improve visual function after impairment caused by facial injection of HA within a certain time window, and to propose a clinically relevant model of retinal ischemia and reperfusion in nonhuman primates. METHODS: Ophthalmic artery (OA) embolization in rhesus monkeys was induced by injecting HA into the OA, and reperfusion was achieved by IATT with hyaluronidase immediately and at 1, 4, and 24 hours after embolization. Digital subtraction angiography and fundus fluorescein angiography were used to evaluate blood flow before and after retinal reperfusion. Retinal structure and function before and after reperfusion were evaluated by electroretinography, hematoxylin and eosin staining, and transmission electron microscopy. scRNA-seq and bioinformatics analyses were used to detect retinal changes.
2. Enhancing fat graft retention through adipose tissue browning: a systematic review.
Across 14 studies, adipose browning emerged around day 7 post-grafting, stabilized by ~3 months, and sometimes reverted to white adipose tissue. Browning enhanced graft retention through early angiogenesis, reduced inflammation, and increased adipogenesis; the cellular origin of beige adipocytes remains unresolved.
Impact: Synthesizes mechanistic and temporal evidence that browning improves fat graft survival, informing biological augmentation strategies in aesthetic and reconstructive surgery.
Clinical Implications: Suggests that inducing browning (e.g., using beige fat or pro-browning stimuli) and optimizing the early post-graft window may improve retention and outcomes in fat grafting.
Key Findings
- Browning appears peripherally in grafts around day 7, stabilizes by ~3 months, and may later revert to white adipose phenotype.
- Browning enhances retention via early angiogenesis, inflammation reduction, and upregulated adipogenesis.
- Evidence base comprises 13 animal studies and 1 clinical report; cellular origin of beige adipocytes remains unclear.
Methodological Strengths
- Systematic, multi-database search with explicit inclusion/exclusion criteria.
- Integration of temporal dynamics and mechanistic pathways across studies.
Limitations
- Predominantly preclinical animal data and one clinical report; heterogeneity precluded meta-analysis.
- Lack of standardized outcome measures and limited long-term clinical data.
Future Directions: Prospective clinical trials to test pro-browning strategies (e.g., beige fat grafting, pharmacologic inducers), standardized endpoints, and lineage-tracing studies to define beige adipocyte origins.
BACKGROUND: Recently, existing researches have gradually recognized the critical biological behaviour played by spontaneous or exogenous-induced browning conversion in fat transplantation. However, no comprehensive review explored the fat grafts remodeling process toward browning and such role in fat graft retention. AIMS: This study aimed to elucidate the behavioral characteristics of browning changes following fat grafting, as well as its benefits and mechanisms on the survival of transplanted fat. METHODS: Databases including Web of science, PubMed, Ovid medline, and Embase were searched from inception through September 2024. Studies related to fat grafts browning in fat transplantation were systematically reviewed, in accordance with the inclusion and exclusion criteria. RESULTS: We evaluated 14 studies including 13 animal works and one clinical report. Five studies directly transplanted fat without any browning induction, while others utilized either beige fat or pre-treated grafts with browning stimuli.Data shown that around the periphery of fat grafts (predominantly in survival zone), early accumulations of graft browning can be observed, dynamically accompanying the stable remodeling of the graft. Post-transplantation spontaneous browning typically begins around day 7, stabilizes after approximately 3 months, and may revert to white adipose tissue. The favorable browning up-regulation behavior of fat graft can enhance graft retention by promoting early angiogenesis, reducing inflammation, and upregulating adipogenesis. The origin of beige adipocytes, whether from the conversion of white adipocytes or the regeneration of progenitor cells, remains underdiscussed.
3. Decades of Scientific Data and Global Media Reporting on Complications in Non-surgical Aesthetic Treatments for a Transparent Safety Profile: Kissing Snow White Awake.
In a mixed-methods synthesis of 231,475 documented complications, dermal fillers accounted for 42% (granulomas, vascular occlusions, delayed hypersensitivity), botulinum toxin A for 15% (mostly mild), and thread lifts showed frequent extrusion and infection. Products with >85% safety probability were identified, and geospatial analyses highlighted disproportionate risks in Asia, with unregulated therapies (e.g., exosomes) flagged as emerging hazards.
Impact: Provides a comprehensive, data-driven safety profile for NSATs, integrating scientific and real-world signals to guide regulation, credentialing, and patient counseling.
Clinical Implications: Supports standardized complication reporting, adoption of ultrasound-guided techniques, and avoidance of unregulated biologics; informs risk communication and device/product selection.
Key Findings
- Dermal fillers were responsible for 42% of complications; botulinum toxin A for 15%, with thread lifts showing frequent extrusion and infection.
- Identified products/procedures with >85% safety probability (e.g., Prabotulinumtoxin A, Juvéderm high-viscosity fillers, Profhilo, APTOS Light Lift, microneedling RF, Ultherapy, EMFACE).
- Geospatial analysis showed 34% of complications reported in Asia; machine learning flagged unregulated therapies (e.g., exosomes) as emerging risks.
Methodological Strengths
- Large-scale, multi-source dataset with advanced statistical and machine learning methods and geospatial mapping.
- Sensitivity analyses to address potential reporting biases.
Limitations
- Heterogeneity and potential bias from media/social sources; not a PRISMA-compliant systematic review.
- Causality cannot be established; underreporting and variable definitions likely.
Future Directions: Implement mandatory adverse event registries, harmonize global regulations, and develop AI-driven real-time surveillance; prospective comparative safety studies of products and techniques.
INTRODUCTION: Non-surgical aesthetic treatments (NSATs) have gained significant traction over the past two decades, prized for their minimally invasive nature, cost-effectiveness, and rapid outcomes. Yet complications associated with these procedures remain underreported, inadequately studied, and inconsistently regulated, compromising patient safety. METHODOLOGY: This mixed-methods study synthesised global data from 457 peer-reviewed studies, 37,250 media articles, 2.28 million social media posts, and regulatory databases, encompassing 231,475 documented complications. Statistical methodologies, including Cox proportional hazards models, Bayesian hierarchical modelling, and geospatial mapping, were employed to evaluate risk trends.